This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Primärliteratur
Rentschler R, Wilbur D: Pyridoxine: a potential local antidote for mitomycin-C extravasation. J Surg Oncol 37: 269–271, 1988.
Argenta LC, Manders EK: Mitomycin C extravasation injuries. Cancer 51: 1080–1082, 1983.
Bertelli G, Dini D, Forno G, et al: Dimethylsulphoxide and cooling after extravasation of antitumour agents. Lancet 341: 1098–1099, 1993.
Bertelli G, Gozza A, Forno GB, et al: Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13: 2851–2855, 1995.
Tsavaris NB, Komitsopoulou P, Karagiaouris P, et al: Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach. Cancer Chemother Pharmacol 30: 330–333, 1992.
Tsavaris NB, Karagiaouris P, Tzannou I, et al: Conservative approach to the treatment of chemotherapy-induced extravasation. J Dermatol Surg Oncol 16: 519–522, 1990.
and a-tocopherole. Eur J Cancer Clin Oncol 23: 327–329, 1987.
]Khanna AK, Khanna A, Asthana AK, et al: Mitomycin C extravasation ulcers. J Surg Oncol 28: 108–110, 1985.
]Bowers DG, Lynch JB: Adriamycin extravasation. Plast Reconstr Surg 61: 86–92, 1978.
Fuller B, Lind M, Bonomi P: Mitomycin C extravasation exacerbated by sunlight. Ann Intern Med 94: 542, 1981.
Moertel CG, Reitemeier RJ, Hahn RG: Mitomycin C therapy in advanced gastrointestinal cancer. JAMA 204: 111–114, 1968.
]Alberts DS, Dorr RT: Case report: topical DMSO for mitomycin-C-induced skin ulceration. Oncol Nurs Forum 18: 693–695, 1991.
]Aizawa H, Tagami H: Delayed tissue necrosis due to mitomycin C. Acta Derm Venereol 67: 364–366, 1987.
Herrera D, Burnham N: DMSO and extravasation of mitomycin. Oncol Nurs Forum 16: 155, 1989.
]Wood HA, Ellerhorst-Ryan JM: Delayed adverse skin reactions associated with mitomycin-C administration. Oncol Nurs Forum 11: 14–18, 1984.
]Bartkowski-Dodds L, Reville B: Extensive tissue ulceration due to apparent sensitivity reactions to mitomycin. Cancer Treat Rep 69: 925–927, 1985.
]Bertelli G: Prevention and management of extravasation of cytotoxic drugs. Drug Safety 12: 245–255, 1995.
]Schneider G: Paravasate von Zytostatika. Diagnostik und Therapie. Am a S. Schneider Verlag, 6. Auflage: 1–17, 1999.
Lehrbuch der Klinischen Pharmazie. Wissenschaftliche Verlagsgesellschaft mbH, 1. Auflage: 268–269, 1998.
]Ignoffo RJ, Friedman MA: Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev 7: 17–27, 1980.
ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, Band 1, 2. Auflage: 35, 1997.
Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 109–118, 1994.
The Cytotoxics Handbook. Radcliffe Medical Press, 3rd edition: 105–124, 1997.
]Mullin S, Beckwith MC, Tyler LS: Prevention and management of antineoplastic extravasation injury. Hosp Pharm 35: 57–76, 2000.
]Schneider SM, Distelhorst CW: Chemotherapy-induced emergencies Semin Oncol 16: 572–578, 1989.
]Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 4: 41–60, 1990.
Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, Band 1, 2. Auflage: A42–44, 1997.
ZytostatikaHerstellung in der Apotheke. Deutscher Apotheker Verlag, Kap. VI-3: 1–9, 2000.
]Cox K, Stuart-Harris R, Abdini G, et al: The management of cytotoxic-drug extravasation: guidelines drawn up by a working party for the Clinical Oncological Society of Australia. Med J Aust 148: 185–189, 1988.
Averbuch SD, Boldt M, Gaudiano G, et al: Experimental chemotherapy-induced skin nekrosis in swine. J Clin Invest 81: 142–148, 1988.
Dorr RT, Soble MJ, Liddil JD, et al: Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxide. J Clin Oncol 4: 1399–1404, 1986.
Hahn SM, Sullivan FJ, De Luca AM, et al: Protection of mitomycin C induced skin extravasation with the nitroxide, 3-carbamoyl-proxyl (3-CP). Int J Oncol 10: 119–123, 1997.
Ignoffo RJ, Tomlin W, Rubinstein E, et al: A model for skin toxicity of antineoplastic drugs: doxorubicin (DOX), mitomycin-C (MMC), and vincristine (VCR). Clin Res 29: 437A, 1981.
Johnston-Early A, Cohen MH: Mitomycin C-induced skin ulceration remote from infusion site. Cancer Treat Rep 65: 529, 1981.
Loth TS, Eversmann WW: Treatment methods for extravasations of chemo- therapeutic agents: a comparative study. J Hand Surg 11A: 388–396, 1986.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Wien
About this chapter
Cite this chapter
Mader, I., Fürst-Weger, P., Mader, R.M., Semenitz, E.I., Terkola, R., Wassertheurer, S.M. (2002). Mitomycin C. In: Paravasation von Zytostatika. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3799-4_37
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3799-4_37
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-3800-7
Online ISBN: 978-3-7091-3799-4
eBook Packages: Springer Book Archive